3.Garrett LD, Thamm DH, Chun R, Dudley R, Vail DM. 4.Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. 5.J Vet Intern Med. 2002;16(6):704-709. doi:10.1892/0891-6640(2002)016<0704:eoacpw>2.3.co;2 6.Curran K, Thamm DH.Retrospectiv...
One hundred and four dogs with nodal Bヽell lymphoma were treated with a response‐based CHOP (RBCHOP) protocol modified based on response to individual drugs during the first chemotherapy cycle. Dogs achieving complete (CR) or partial response (PR) at week 3, following treatment with ...
Since peripheral blood cell composition can be affected by several non-oncological causes, the development of larger multicenter studies with homogeneous inclusion criteria could help to better determine the true predictive values of blood cell ratios in dogs' DLBCL treated with CHOP chemotherapy.doi:...
Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma Forty-four dogs with multicentric lymphoma were treated using a cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) induction protocol or treated using a cyclophosphamide, mitoxantr...
Chemotherapy isa common treatment for dogs with lymphoma; however, chemotherapy may result in alterations in behaviour. Little research has focused on the behavioural changes. Hence, the purpose of this project was to investigate sickness behaviour in dogs with lymphoma treated with chemotherapy.J. ...
CHOP chemotherapy for first-line treatment of canine lymphoma has been well-described. The objective of this study was to evaluate factors that influenced the second remission of dogs that were re-induced with CHOP at relapse.Methods: Medical records of dogs with multicentric lymphoma were ...
ChemotherapyRNA sequencingCanine lymphoma, the most common hematological cancer in dogs, shares many molecular and clinical characteristics with human Non-Hodgkin lymphoma (NHL). The standard treatment for canine lymphoma is "CHOP" multiagent chemotherapy protocol consisting of Cyclophosphamide, Doxorubicin ...
One hundred thirty-four client-owned dogs with multicentric lymphoma were treated with a 15-week CHOP chemotherapy protocol. The overall response rate was 98% with 104 dogs experiencing a complete response (CR). The median progression-free survival (PFS) time for all dogs was 176 days, and ...
chemotherapymulticentric lymphomamitoxantroneThe purpose of this study was to evaluate the efficacy of adding mitoxantrone to a cyclophosphamide, doxorubicin, vincristine, l-asparaginase and prednisone containing protocol. Sixty-five dogs with multicentric lymphoma were evaluated for overall remission and ...
Most cats with lymphoma treated with multiple-agent chemotherapy protocols are expected to live 6 to 9 months; approximately 20% of the cats live more than 1 year. Most dogs with lymphoma treated in a similar fashion are expected to live 12 to 16 months; approximately 20% to 30% of the ...